Event content

Manufacturers face unique quality challenges that can hinder progress. In this session hear about quality challenges in Cell and Gene Therapy (CGT) and learn common practices for overcoming them: • The amc was formed in 2010 to focus on manufacturing when everything at the time was focused on clinical...

The European ban on the use of titanium dioxide for food use has called into question its use in pharmaceutical products because its pharmaceutical use was predicated on its approval for food use. The European ban is not based on hard science or a real safety issue, but on the precautionary principle. This...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

Get the inside focus on the latest drug pricing developments in the US market. Listen to the current legislator updates and how it will affect patient costs while reviewing the rising manufacturing costs from inflation and supply constraints and the market’s reaction: • Examining current manufacture ...

• Market needs for a device to deliver high drug loads to lungs. • Introduction to the Orbital device – features and benefits. • Comparative performance of Orbital to other DPI devices. • Different types of molecules and formulations made using different particle engineering technologies, inc...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

Connecting medication and medical devices to the internet can enhance product protection, improve patient safety and outcomes, and optimize processes along complex supply chains. NFC-RFID technologies are increasingly used to provide connectivity benefits more securely and efficiently, ensuring that pharma...

Polysorbates are intensively used in biologics formulation as stabilizer due to their propensity to inhibit aggregation at interfaces but possess low intrinsic stability. In this study, the chemical stability of KLEPTOSE® HPBCDs are compared with polysorbates under various stress conditions.

Wh...

In Dec 2021, Thermo Fisher completed the acquisition of PPD, Inc, a leading global provider of clinical research services to the biopharma and biotech industry. With the addition of PPD, Thermo Fisher will offer a comprehensive suite of world-class services across the clinical development spectrum – from s...

• Digitalization in biopharma is more complex than just replacing paper documents with electronic counterparts or hiring data scientist • In the context of bioprocessing, the industry needs a better way to transition quickly from lab to clinical to commercial manufacturing • Speed to clinic require...

• What is the best strategy to access novel therapeutic approaches and technologies? • Licensing vs M&A? • How to build a stake in competitive future therapies and innovations • How to beat competitors to your desired goals • Exploiting innovation arising in non-medical fields and other indust...

In this webinar, originally broadcast as part of the Pharmapack Europe show, speaker Aurelio Areas, Engagement Manager, IQVIA will give us a look at the global outlook of the pharma industry as it emerges from the pandemic with a focus on drug delivery trends. This session analyses current dynamics in drug...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Corinne Ondo, Head of Sourcing Production Materials Biotech & Healthcare Innovation, Merck discusses how Healthcare is currently improving packaging reuse in its supply chain by working in close partnership with its suppliers. By...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Robert Schultheis, Founder & Chief Technology Officer, ZebraSci discusses: • Probabilistic vs deterministic CCI Testing • Presentation of the different deterministic CCI testing methods with applications and limitations ...

Originally broadcast as part of the CPHI Monthly Podcasts Series Smart devices and their companion apps are transforming the patient experience and moving healthcare management from hospitals to homes. However, this digital shift can prove challenging for some users. In the latest instalment of our p...

In this webinar, originally broadcast as part of CPHI NA, Michael Sassano, CEO and Chairman, Somai Pharmaceuticals discusses: • Global Pharmaceutical Cannabis market and the history of recent growth • Current trends in the Medical Cannabis market versus the Canadian and American experience • Herbal M...

As global governments and businesses increasingly make bold claims and commitments to tackle the climate emergency, investors are starting to take note by using the ESG framework to move beyond environmental concerns and focus on a company's impact on all the different ecosystems it operates in. The ris...

Discuss strategies and methodologies to develop scalable, robust, and cost-effective manufacturing processes for allogeneic cell therapies Showcase how induced pluripotent stem cells (iPSC) are being used as renewable sources of allogeneic cancer therapies Demonstrate the criticality of GMP manufacturing...

Join our panel discussion, where out experts will conduct a deep dive through the challenges in drug manufacturing. Key discussion points include: Bottlenecks in skilled workforce and what can be done to overcome this Assessing the challenges in both product and manufacturing quality and identifying...